Source: USA Today
by Maddie Salamone & Caitlin Styrsky
“A new Medicare pilot program covers hemp-derived cannabidiol (CBD) products to treat certain patients, even as Congress is moving forward with a law that will effectively wipe those same products off the market. The resulting policy quagmire threatens patient access, undermines the work of entrepreneurs and highlights a deeper truth: Hemp already plays a role in American health care, whether federal lawmakers are ready to acknowledge it or not. Millions of Americans across the country are using full-spectrum CBD products not for recreation, but for relief.” (09/08/26)
https://www.usatoday.com/story/opinion/2026/09/08/medicare-cbd-costs-health-insurance/91547732007/